Showing 97–102 of 102 resultsSorted by popularity
Ipamorelin is a third-generation selective ghrelin receptor agonist pentapeptide that triggers consistent growth hormone release without activating ACTH, prolactin, or cortisol pathways. Its 2-hour half-life produces a clean physiological GH pulse ideal for recovery and body composition research.
Tesamorelin + Ipamorelin is a complementary GHRH/GHRP stack that combines a stabilized 44-amino acid GHRH analog with a selective ghrelin receptor agonist. Tesamorelin drives sustained visceral fat lipolysis while Ipamorelin amplifies GH pulsatility without ACTH or prolactin side effects.
Long-acting GLP-1 receptor agonist for appetite regulation and metabolic research. Investigate weight management pathways.
Cagri-Sema is a integrated dual-peptide blend of Cagrilintide and Semaglutide that simultaneously activates amylin/calcitonin and GLP-1 receptors for full-scale appetite suppression and glycemic control. This combination overcomes the receptor saturation plateau of GLP-1 monotherapy.
HCG functions biologically almost identically to pituitary-derived luteinizing hormone (LH).
Adipotide FTPP is a targeted peptidomimetic that selectively binds prohibitin on white adipose vasculature, triggering mitochondrial apoptosis and eliminating fat tissue infrastructure. Unlike lipolytic agents that merely empty fat cells, Adipotide fundamentally destroys them.
End of content
End of content
No products in the cart.
